Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans

NCT05794776 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-05-10

No results posted yet for this study

Summary

This trial investigates the effect of BurstDR and tonic spinal cord stimulation (SCS) on glucose metabolism and heart rate variability in patients with neuropathic pain.

Conditions

  • Spinal Cord Stimulation
  • Insulin Secretion

Interventions

DEVICE

BurstDR stimulation

BurstDR spinal cord stimulation

DEVICE

Tonic stimulation

Tonic spinal cord stimulation

DEVICE

No stimulation

Stimulator is switched off

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Matthias Morgalla, Prof. · Universitaetsklinikum Tuebingen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-16
Primary Completion
2023-09-01
Completion
2023-10-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794776 on ClinicalTrials.gov